Chronic Fatigue Syndrome Drug Market, Global Outlook and Forecast 2022-2028

February 2022 | 64 pages | ID: C2840363E1D7EN
Market Monitor Global

Abstracts

Chronic fatigue syndrome, also known as Myalgic encephalomyelitis, is a chronic disease which lasts for six months and affects the central nervous system and the immune system. The disease leads to musculoskeletal disorders, impairment of long term memory, and disturbed sleep patterns. This results in substantial decline in social, occupational, educational, and personal activity among patients. There are no specific biomarkers or tests to diagnose chronic fatigue syndrome. Symptoms include sore throat, muscle pain, headache, and fatigue, which continues for months or years.

This report contains market size and forecasts of Chronic Fatigue Syndrome Drug in Global, including the following market information:

Global Chronic Fatigue Syndrome Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Chronic Fatigue Syndrome Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Pain Relievers and NSAIDs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Chronic Fatigue Syndrome Drug include Pfizer, Teva, Mylan, Depomed, Mallinckrodt Pharmaceuticals, Eli Lilly, Bayer, Novartis and Sun Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chronic Fatigue Syndrome Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Chronic Fatigue Syndrome Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Chronic Fatigue Syndrome Drug Market Segment Percentages, by Type, 2021 (%)

• Pain Relievers and NSAIDs
• Antidepressant and Antipsychotic Drugs
• Antimicrobial and Immunomodulatory Drugs

Global Chronic Fatigue Syndrome Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Chronic Fatigue Syndrome Drug Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Retail Pharmacy
• Other

Global Chronic Fatigue Syndrome Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Chronic Fatigue Syndrome Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Chronic Fatigue Syndrome Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Chronic Fatigue Syndrome Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Teva
• Mylan
• Depomed
• Mallinckrodt Pharmaceuticals
• Eli Lilly
• Bayer
• Novartis
• Sun Pharmaceutical
• Astrazeneca
• Lundbeck
• Arbor Pharma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Chronic Fatigue Syndrome Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Chronic Fatigue Syndrome Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CHRONIC FATIGUE SYNDROME DRUG OVERALL MARKET SIZE

2.1 Global Chronic Fatigue Syndrome Drug Market Size: 2021 VS 2028
2.2 Global Chronic Fatigue Syndrome Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Chronic Fatigue Syndrome Drug Players in Global Market
3.2 Top Global Chronic Fatigue Syndrome Drug Companies Ranked by Revenue
3.3 Global Chronic Fatigue Syndrome Drug Revenue by Companies
3.4 Top 3 and Top 5 Chronic Fatigue Syndrome Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Chronic Fatigue Syndrome Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Chronic Fatigue Syndrome Drug Players in Global Market
  3.6.1 List of Global Tier 1 Chronic Fatigue Syndrome Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Chronic Fatigue Syndrome Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Chronic Fatigue Syndrome Drug Market Size Markets, 2021 & 2028
  4.1.2 Pain Relievers and NSAIDs
  4.1.3 Antidepressant and Antipsychotic Drugs
  4.1.4 Antimicrobial and Immunomodulatory Drugs
4.2 By Type - Global Chronic Fatigue Syndrome Drug Revenue & Forecasts
  4.2.1 By Type - Global Chronic Fatigue Syndrome Drug Revenue, 2017-2022
  4.2.2 By Type - Global Chronic Fatigue Syndrome Drug Revenue, 2023-2028
  4.2.3 By Type - Global Chronic Fatigue Syndrome Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Chronic Fatigue Syndrome Drug Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Retail Pharmacy
  5.1.4 Other
5.2 By Application - Global Chronic Fatigue Syndrome Drug Revenue & Forecasts
  5.2.1 By Application - Global Chronic Fatigue Syndrome Drug Revenue, 2017-2022
  5.2.2 By Application - Global Chronic Fatigue Syndrome Drug Revenue, 2023-2028
  5.2.3 By Application - Global Chronic Fatigue Syndrome Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Chronic Fatigue Syndrome Drug Market Size, 2021 & 2028
6.2 By Region - Global Chronic Fatigue Syndrome Drug Revenue & Forecasts
  6.2.1 By Region - Global Chronic Fatigue Syndrome Drug Revenue, 2017-2022
  6.2.2 By Region - Global Chronic Fatigue Syndrome Drug Revenue, 2023-2028
  6.2.3 By Region - Global Chronic Fatigue Syndrome Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Chronic Fatigue Syndrome Drug Revenue, 2017-2028
  6.3.2 US Chronic Fatigue Syndrome Drug Market Size, 2017-2028
  6.3.3 Canada Chronic Fatigue Syndrome Drug Market Size, 2017-2028
  6.3.4 Mexico Chronic Fatigue Syndrome Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Chronic Fatigue Syndrome Drug Revenue, 2017-2028
  6.4.2 Germany Chronic Fatigue Syndrome Drug Market Size, 2017-2028
  6.4.3 France Chronic Fatigue Syndrome Drug Market Size, 2017-2028
  6.4.4 U.K. Chronic Fatigue Syndrome Drug Market Size, 2017-2028
  6.4.5 Italy Chronic Fatigue Syndrome Drug Market Size, 2017-2028
  6.4.6 Russia Chronic Fatigue Syndrome Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Chronic Fatigue Syndrome Drug Market Size, 2017-2028
  6.4.8 Benelux Chronic Fatigue Syndrome Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Chronic Fatigue Syndrome Drug Revenue, 2017-2028
  6.5.2 China Chronic Fatigue Syndrome Drug Market Size, 2017-2028
  6.5.3 Japan Chronic Fatigue Syndrome Drug Market Size, 2017-2028
  6.5.4 South Korea Chronic Fatigue Syndrome Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Chronic Fatigue Syndrome Drug Market Size, 2017-2028
  6.5.6 India Chronic Fatigue Syndrome Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Chronic Fatigue Syndrome Drug Revenue, 2017-2028
  6.6.2 Brazil Chronic Fatigue Syndrome Drug Market Size, 2017-2028
  6.6.3 Argentina Chronic Fatigue Syndrome Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Chronic Fatigue Syndrome Drug Revenue, 2017-2028
  6.7.2 Turkey Chronic Fatigue Syndrome Drug Market Size, 2017-2028
  6.7.3 Israel Chronic Fatigue Syndrome Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Chronic Fatigue Syndrome Drug Market Size, 2017-2028
  6.7.5 UAE Chronic Fatigue Syndrome Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Chronic Fatigue Syndrome Drug Major Product Offerings
  7.1.4 Pfizer Chronic Fatigue Syndrome Drug Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Teva
  7.2.1 Teva Corporate Summary
  7.2.2 Teva Business Overview
  7.2.3 Teva Chronic Fatigue Syndrome Drug Major Product Offerings
  7.2.4 Teva Chronic Fatigue Syndrome Drug Revenue in Global Market (2017-2022)
  7.2.5 Teva Key News
7.3 Mylan
  7.3.1 Mylan Corporate Summary
  7.3.2 Mylan Business Overview
  7.3.3 Mylan Chronic Fatigue Syndrome Drug Major Product Offerings
  7.3.4 Mylan Chronic Fatigue Syndrome Drug Revenue in Global Market (2017-2022)
  7.3.5 Mylan Key News
7.4 Depomed
  7.4.1 Depomed Corporate Summary
  7.4.2 Depomed Business Overview
  7.4.3 Depomed Chronic Fatigue Syndrome Drug Major Product Offerings
  7.4.4 Depomed Chronic Fatigue Syndrome Drug Revenue in Global Market (2017-2022)
  7.4.5 Depomed Key News
7.5 Mallinckrodt Pharmaceuticals
  7.5.1 Mallinckrodt Pharmaceuticals Corporate Summary
  7.5.2 Mallinckrodt Pharmaceuticals Business Overview
  7.5.3 Mallinckrodt Pharmaceuticals Chronic Fatigue Syndrome Drug Major Product Offerings
  7.5.4 Mallinckrodt Pharmaceuticals Chronic Fatigue Syndrome Drug Revenue in Global Market (2017-2022)
  7.5.5 Mallinckrodt Pharmaceuticals Key News
7.6 Eli Lilly
  7.6.1 Eli Lilly Corporate Summary
  7.6.2 Eli Lilly Business Overview
  7.6.3 Eli Lilly Chronic Fatigue Syndrome Drug Major Product Offerings
  7.6.4 Eli Lilly Chronic Fatigue Syndrome Drug Revenue in Global Market (2017-2022)
  7.6.5 Eli Lilly Key News
7.7 Bayer
  7.7.1 Bayer Corporate Summary
  7.7.2 Bayer Business Overview
  7.7.3 Bayer Chronic Fatigue Syndrome Drug Major Product Offerings
  7.7.4 Bayer Chronic Fatigue Syndrome Drug Revenue in Global Market (2017-2022)
  7.7.5 Bayer Key News
7.8 Novartis
  7.8.1 Novartis Corporate Summary
  7.8.2 Novartis Business Overview
  7.8.3 Novartis Chronic Fatigue Syndrome Drug Major Product Offerings
  7.8.4 Novartis Chronic Fatigue Syndrome Drug Revenue in Global Market (2017-2022)
  7.8.5 Novartis Key News
7.9 Sun Pharmaceutical
  7.9.1 Sun Pharmaceutical Corporate Summary
  7.9.2 Sun Pharmaceutical Business Overview
  7.9.3 Sun Pharmaceutical Chronic Fatigue Syndrome Drug Major Product Offerings
  7.9.4 Sun Pharmaceutical Chronic Fatigue Syndrome Drug Revenue in Global Market (2017-2022)
  7.9.5 Sun Pharmaceutical Key News
7.10 Astrazeneca
  7.10.1 Astrazeneca Corporate Summary
  7.10.2 Astrazeneca Business Overview
  7.10.3 Astrazeneca Chronic Fatigue Syndrome Drug Major Product Offerings
  7.10.4 Astrazeneca Chronic Fatigue Syndrome Drug Revenue in Global Market (2017-2022)
  7.10.5 Astrazeneca Key News
7.11 Lundbeck
  7.11.1 Lundbeck Corporate Summary
  7.11.2 Lundbeck Business Overview
  7.11.3 Lundbeck Chronic Fatigue Syndrome Drug Major Product Offerings
  7.11.4 Lundbeck Chronic Fatigue Syndrome Drug Revenue in Global Market (2017-2022)
  7.11.5 Lundbeck Key News
7.12 Arbor Pharma
  7.12.1 Arbor Pharma Corporate Summary
  7.12.2 Arbor Pharma Business Overview
  7.12.3 Arbor Pharma Chronic Fatigue Syndrome Drug Major Product Offerings
  7.12.4 Arbor Pharma Chronic Fatigue Syndrome Drug Revenue in Global Market (2017-2022)
  7.12.5 Arbor Pharma Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Chronic Fatigue Syndrome Drug Market Opportunities & Trends in Global Market
Table 2. Chronic Fatigue Syndrome Drug Market Drivers in Global Market
Table 3. Chronic Fatigue Syndrome Drug Market Restraints in Global Market
Table 4. Key Players of Chronic Fatigue Syndrome Drug in Global Market
Table 5. Top Chronic Fatigue Syndrome Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Chronic Fatigue Syndrome Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Chronic Fatigue Syndrome Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Chronic Fatigue Syndrome Drug Product Type
Table 9. List of Global Tier 1 Chronic Fatigue Syndrome Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chronic Fatigue Syndrome Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Chronic Fatigue Syndrome Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Chronic Fatigue Syndrome Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Chronic Fatigue Syndrome Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Chronic Fatigue Syndrome Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Chronic Fatigue Syndrome Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Chronic Fatigue Syndrome Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Chronic Fatigue Syndrome Drug Product Offerings
Table 32. Pfizer Chronic Fatigue Syndrome Drug Revenue (US$, Mn), (2017-2022)
Table 33. Teva Corporate Summary
Table 34. Teva Chronic Fatigue Syndrome Drug Product Offerings
Table 35. Teva Chronic Fatigue Syndrome Drug Revenue (US$, Mn), (2017-2022)
Table 36. Mylan Corporate Summary
Table 37. Mylan Chronic Fatigue Syndrome Drug Product Offerings
Table 38. Mylan Chronic Fatigue Syndrome Drug Revenue (US$, Mn), (2017-2022)
Table 39. Depomed Corporate Summary
Table 40. Depomed Chronic Fatigue Syndrome Drug Product Offerings
Table 41. Depomed Chronic Fatigue Syndrome Drug Revenue (US$, Mn), (2017-2022)
Table 42. Mallinckrodt Pharmaceuticals Corporate Summary
Table 43. Mallinckrodt Pharmaceuticals Chronic Fatigue Syndrome Drug Product Offerings
Table 44. Mallinckrodt Pharmaceuticals Chronic Fatigue Syndrome Drug Revenue (US$, Mn), (2017-2022)
Table 45. Eli Lilly Corporate Summary
Table 46. Eli Lilly Chronic Fatigue Syndrome Drug Product Offerings
Table 47. Eli Lilly Chronic Fatigue Syndrome Drug Revenue (US$, Mn), (2017-2022)
Table 48. Bayer Corporate Summary
Table 49. Bayer Chronic Fatigue Syndrome Drug Product Offerings
Table 50. Bayer Chronic Fatigue Syndrome Drug Revenue (US$, Mn), (2017-2022)
Table 51. Novartis Corporate Summary
Table 52. Novartis Chronic Fatigue Syndrome Drug Product Offerings
Table 53. Novartis Chronic Fatigue Syndrome Drug Revenue (US$, Mn), (2017-2022)
Table 54. Sun Pharmaceutical Corporate Summary
Table 55. Sun Pharmaceutical Chronic Fatigue Syndrome Drug Product Offerings
Table 56. Sun Pharmaceutical Chronic Fatigue Syndrome Drug Revenue (US$, Mn), (2017-2022)
Table 57. Astrazeneca Corporate Summary
Table 58. Astrazeneca Chronic Fatigue Syndrome Drug Product Offerings
Table 59. Astrazeneca Chronic Fatigue Syndrome Drug Revenue (US$, Mn), (2017-2022)
Table 60. Lundbeck Corporate Summary
Table 61. Lundbeck Chronic Fatigue Syndrome Drug Product Offerings
Table 62. Lundbeck Chronic Fatigue Syndrome Drug Revenue (US$, Mn), (2017-2022)
Table 63. Arbor Pharma Corporate Summary
Table 64. Arbor Pharma Chronic Fatigue Syndrome Drug Product Offerings
Table 65. Arbor Pharma Chronic Fatigue Syndrome Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Chronic Fatigue Syndrome Drug Segment by Type in 2021
Figure 2. Chronic Fatigue Syndrome Drug Segment by Application in 2021
Figure 3. Global Chronic Fatigue Syndrome Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Chronic Fatigue Syndrome Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Chronic Fatigue Syndrome Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Chronic Fatigue Syndrome Drug Revenue in 2021
Figure 8. By Type - Global Chronic Fatigue Syndrome Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Chronic Fatigue Syndrome Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Chronic Fatigue Syndrome Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Chronic Fatigue Syndrome Drug Revenue Market Share, 2017-2028
Figure 12. US Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Chronic Fatigue Syndrome Drug Revenue Market Share, 2017-2028
Figure 16. Germany Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Chronic Fatigue Syndrome Drug Revenue Market Share, 2017-2028
Figure 24. China Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Chronic Fatigue Syndrome Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Chronic Fatigue Syndrome Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Chronic Fatigue Syndrome Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Chronic Fatigue Syndrome Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Teva Chronic Fatigue Syndrome Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Mylan Chronic Fatigue Syndrome Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Depomed Chronic Fatigue Syndrome Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Mallinckrodt Pharmaceuticals Chronic Fatigue Syndrome Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Eli Lilly Chronic Fatigue Syndrome Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bayer Chronic Fatigue Syndrome Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Novartis Chronic Fatigue Syndrome Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Sun Pharmaceutical Chronic Fatigue Syndrome Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Astrazeneca Chronic Fatigue Syndrome Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Lundbeck Chronic Fatigue Syndrome Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Arbor Pharma Chronic Fatigue Syndrome Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)